Anti-TNF-Alpha-Adalimumab Therapy Is Associated with Persistent Improvement of Endothelial Function without Progression of Carotid Intima-Media Wall Thickness in Patients with Rheumatoid Arthritis Refractory to Conventional Therapy

• Κύριοι συγγραφείς: Carlos Gonzalez-Juanatey (Συγγραφέας), Tomas R. Vazquez-Rodriguez (Συγγραφέας), Jose A. Miranda-Filloy (Συγγραφέας), Ines Gomez-Acebo (Συγγραφέας), Ana Testa (Συγγραφέας), Carlos Garcia-Porrua (Συγγραφέας), Amalia Sanchez-Andrade (Συγγραφέας), Javier Llorca (Συγγραφέας), Miguel A. González-Gay (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Hindawi Limited, 2012-01-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

To determine whether treatment with the anti-TNF-alpha blocker adalimumab yields persistent improvement of endothelial function and prevents from morphological progression of subclinical atherosclerosis in patients with rheumatoid arthritis (RA) refractory to conventional therapy, a series of 34 con...